ABSTRACT
INTRODUCTION
Etoposide [(4'-demethyl-epipodophylotoxin 9-[4,6-O-(R)-ethylidene-β-D-glucopyranoside] is a semi-synthetic derivative of epipodophyllotoxins (figure 1) obtained from plant Mandragora officianarum. It was introduced in clinical practice in early 1970's and now used in a large number of human malignant diseases including leukemia, lymphomas and lung cancer [1] . It inhibits topoisomerase II activity, the enzyme is involved in uncoiling DNA, thus affecting its repair and replication [2] . Both intravenous and oral dosage forms are used. It is often given in combination with other antineoplastic drugs of different mode of action like cisplatin [3] [4] .
EXPERIMENTAL

Chemicals and materials
Etoposide was kindly supplied by Pharmedic Laboratories Pvt. Ltd. Lahore, (Pakistan) with 99.64% purity. Methanol and HCl were of HPLC grade from Merck, Germany. The column C 18 (ODS Hypersil) was purchased from Thermo Electron Corporation, UK. Nefopam (internal standard) is of analytical grade.
Instrumentation and HPLC conditions A Sykam series chromatographic system consisting of solvent delivery system (S-2100), Injector value Bracket (S 5111) and UV / Vis detector (S-3210) with column C 18 ODS Hypersil column having dimensions 250 × 4.6 mm with 5µm particle size was used. The detection was set at 204 nm. The mobile phase consisted of methanol and water (1:1) and pH was maintained at 4.20 with 0.2N HCl. The flow rate was maintained at 1.0 mL min -1 . The analyte was injected into a loop of 20 µl. The system was attached with a computer soft ware (Clarity ver. 2.5) to analyze and calculate data.
Preparation of mobile phase Mobile phase was prepared by mixing HPLC grade methanol with double distilled filtered water (1:1) and contents filtered through 0.45 µm membrane filter (Sartorius Stedim, Germany). The pH was adjusted to 4.20 with 0.2-N HCl. Mobile phase was used after degassing.
Standard preparation Stock solutions (1.0 mg mL -1 ) each of etoposide and internal standard nefopam were prepared in the mobile phase. A standard solution of nefopam, at fixed concentration of 500 µg mL -1 was prepared by dilution of stock solution. Further dilutions of etoposide were made up to 0.03 µg mL -1 . Fresh solutions were prepared daily, filtered, and degassed by sonication.
Sample preparation
The samples were prepared by dissolving two injectable brands of etoposide in mobile phase to yield 1.0 mg mL -1 solution and further dilutions were made with mobile phase for analysis.
RESULTS AND DISCUSSION
Analytical method development
In the HPLC method development process, various systems of mobile phase with several combinations were tested. Table 1 shows the various mobile phases used during the development of the proposed method. Finally, methanol: water (1:1) at pH 4.20 was found to be the most suitable at flow rate of 1.0 mL min -1 . Run time of every elution was 10 min. Nefopam was selected as an internal standard because it was found stable under the experimental conditions, not reactive with the drug and eluted first with reasonable retention time.
Peak identification
The peak of etoposide was identified by comparison of retention times of sample and standard solution, the increase or decrease in size of the peak Liquid chromatography is a sensitive and accurate method used for quantitative analysis of drugs. Several methods for the determination of etoposide include HPLC with UV detection [5] [6] [7] [8] , fluorescence detection [9] , and electrochemical detection [10] [11] . It has also been determined by LC-MS method [12] [13] and ELISA method [14] . These previously published methods use mixture of expensive organic solvents or demand costly equipment [11] [12] [13] . There was a need to develop and validate a simple and cost effective HPLC method for the determination of etoposide. The present work therefore is an alternative to previously published work and is simple and cost effective using one organic solvent as mobile phase.
e-mail: drashraf_iub@yahoo.com; dr.m.ashraf@gmail.com with change of concentration of standard solution was determined. During application of this method, the etoposide was eluted at 6.6 min. Nefopam also co-eluted at 1.76 min as an internal standard. A representative chromatogram is given in figure 2. . LOD and LOQ (limit of quantification) values were determined with suitable accuracy and precision between batches and within batches and data is given in table 2-3. Bench top stability method was employed in stability studies of etoposide. The drug at two different concentrations was studied in triplicate with an interval of 2 hours till 6 hours as given in table 5. Data shows that the drug solution was stable within the experimental conditions of the developed method as depicted by CV (<3%).
Robustness
The method was found robust under varied conditions of flow rate (± 0.03 mL min -1 ), mobile phase compositions (± 2.0 mL of organic component) and wavelength (± 5 nm) since no marked changes were observed in the elution profiles (data not shown).
APPLICATIONS OF METHOD
The developed method has an importance in the quality control and quality assurance of etoposide formulations during manufacturing in industry as well as monitoring the quality of different brands of etoposide formulations especially the injectables at drug testing laboratories or other regulatory agencies. This method is recommended for industrial analysis of etoposide. The application of this method is clearly demonstrated in table 6 which exhibits the quantitative analysis of two different injectable formulations of etoposide available in the market. 
Method validation
Following parameters were evaluated step by step to ensure the testing of significant method characteristics according to good analytical practice guidelines.
Linearity and range
The standard stock solution of etoposide was diluted with mobile phase to prepare a set of solutions of different concentrations ranging from 0.25 to 62.50 µg mL -1 (table 2) . Each drug concentrations was run in triplicates and data was plotted to calculate the parameters of standard curve. The values of slope, intercept and r-square for etoposide were 63.565, 4.608 and 0.9982, respectively. The values of these parameters were found to be consistent with FDA guidelines of method validation. (table 3) .
Precision
The precision of this analytical method was performed by repeating for three different days. The CV within-batch for low, medium and high concentrations were 2.1095%, 0.9413% and between batches were 1.2506%, 
CONCLUSIONS
The developed method is simple, cost effective, accurate and an alternative to other methods. The proposed method is suitable for the analysis of active ingredient as well as injectable dosage form of etoposide. It has short analysis time, low limit of detection (0.03 µg mL -1 ), with nefopam used as new internal standard and a simple mobile phase with one organic component. The accuracy of the developed method was 99.4% and 99.7% with RSD of 0.3%. which was within the limits of FDA guidelines.
